Objective:The mechanism of Chinese herbal medicine"Bi xie and Tu fuling"on the treatment of gouty arthritis was explored through network pharmacological methods.Methods:First,the TCMSP Chinese medicine syste...Objective:The mechanism of Chinese herbal medicine"Bi xie and Tu fuling"on the treatment of gouty arthritis was explored through network pharmacological methods.Methods:First,the TCMSP Chinese medicine system pharmacology database and analysis platform were used to define the bioavailability(OB)30%and drug-likeness(DL)0.18.Database to mine genetic targets related to gouty arthritis disease.Finally,the two genes are intersected to construct a Chinese medicine regulatory network of Chinese medicine-components-target genes-disease.The genes in the network are used to construct a protein interaction network to find core genes for analysis of GO and KEGG.Results:There were a total of 84 active ingredients in Chinese medicine Poria and Poria cocos,and 17 effective ingredients and 180 genetic targets were obtained after screening.600 disease targets for gouty arthritis were identified,and 58 were common target genes for both.PPI network analysis revealed that IL1β,VEGFA,MAPK1,IL10,and PTGS2 may be drugs for treating gouty arthritis.Key targets.GO enrichment analysis identified 1,399 entries(P<0.05),of which biological processes mainly include biological stimulation,biological regulation,cell metabolism,etc;KEGG pathway enrichment analysis identified 152 signal pathways,of which signal pathways involved inflammation,metabolism,In terms of aging,mainly including the IL-4,IL-10,IL-13,IL-17signal pathway,etc.Conclusion:"Bi xie and Tu fuling"drugs have anti-inflammatory and immunological effects on gouty arthritis through multiple targets and multiple pathways.The mechanism of lowering uric acid and protecting liver and kidney is not clear.It needs molecular biology research to improve it.The mechanism of the action of the"Bi xie and Tu fuling"medicine pair provides new ideas for the clinical prescriptions.展开更多
目的了解萆薢分清丸联合左氧氟沙星针剂对于多重耐药细菌所致尿路感染的临床疗效。方法选取在急诊内科住院的尿路感染患者。以第1次尿液培养阳性,致病菌株为革兰阴性杆菌或革兰阳性球菌的68例患者为研究对象。其中男30例,女38例,年龄(67...目的了解萆薢分清丸联合左氧氟沙星针剂对于多重耐药细菌所致尿路感染的临床疗效。方法选取在急诊内科住院的尿路感染患者。以第1次尿液培养阳性,致病菌株为革兰阴性杆菌或革兰阳性球菌的68例患者为研究对象。其中男30例,女38例,年龄(67.9±14.6)岁。观察组以口服萆薢分清丸(6 g,1天2次)联合左氧氟沙星(100 m L,1天2次)静脉滴注;对照组单纯静脉滴注左氧氟沙星(100 m L,1天2次)治疗。两组治疗周期均为7 d。结果 68例培养阳性患者中,革兰阴性菌46株,其中产超广谱β内酰胺酶的多重耐药菌株30株,革兰阳性菌30株,其中甲氧西林耐药者9株及肠球菌10株。药敏试验结果显示,萆薢分清丸联合左氧氟沙星对多重耐药细菌所致下尿路感染的总有效率为78.2%(18/23),细菌学总有效率为73.9%(17/23),与对照组比较(总有效率为45.0%,细菌学总有效率为25.0%)均差异有统计学意义(P<0.05)。未发生与药物相关的严重不良事件。结论急诊病人常见的尿路感染病原菌中多重耐药细菌比例高,萆薢分清丸联合左氧氟沙星用于治疗多重耐药菌引起的尿路感染疗效良好。展开更多
基金National administration of TCM base special fund(No.JDZX2015277)Beijing municipal science and technology commission science and technology star project(No.Z191100001119025)
文摘Objective:The mechanism of Chinese herbal medicine"Bi xie and Tu fuling"on the treatment of gouty arthritis was explored through network pharmacological methods.Methods:First,the TCMSP Chinese medicine system pharmacology database and analysis platform were used to define the bioavailability(OB)30%and drug-likeness(DL)0.18.Database to mine genetic targets related to gouty arthritis disease.Finally,the two genes are intersected to construct a Chinese medicine regulatory network of Chinese medicine-components-target genes-disease.The genes in the network are used to construct a protein interaction network to find core genes for analysis of GO and KEGG.Results:There were a total of 84 active ingredients in Chinese medicine Poria and Poria cocos,and 17 effective ingredients and 180 genetic targets were obtained after screening.600 disease targets for gouty arthritis were identified,and 58 were common target genes for both.PPI network analysis revealed that IL1β,VEGFA,MAPK1,IL10,and PTGS2 may be drugs for treating gouty arthritis.Key targets.GO enrichment analysis identified 1,399 entries(P<0.05),of which biological processes mainly include biological stimulation,biological regulation,cell metabolism,etc;KEGG pathway enrichment analysis identified 152 signal pathways,of which signal pathways involved inflammation,metabolism,In terms of aging,mainly including the IL-4,IL-10,IL-13,IL-17signal pathway,etc.Conclusion:"Bi xie and Tu fuling"drugs have anti-inflammatory and immunological effects on gouty arthritis through multiple targets and multiple pathways.The mechanism of lowering uric acid and protecting liver and kidney is not clear.It needs molecular biology research to improve it.The mechanism of the action of the"Bi xie and Tu fuling"medicine pair provides new ideas for the clinical prescriptions.
文摘目的了解萆薢分清丸联合左氧氟沙星针剂对于多重耐药细菌所致尿路感染的临床疗效。方法选取在急诊内科住院的尿路感染患者。以第1次尿液培养阳性,致病菌株为革兰阴性杆菌或革兰阳性球菌的68例患者为研究对象。其中男30例,女38例,年龄(67.9±14.6)岁。观察组以口服萆薢分清丸(6 g,1天2次)联合左氧氟沙星(100 m L,1天2次)静脉滴注;对照组单纯静脉滴注左氧氟沙星(100 m L,1天2次)治疗。两组治疗周期均为7 d。结果 68例培养阳性患者中,革兰阴性菌46株,其中产超广谱β内酰胺酶的多重耐药菌株30株,革兰阳性菌30株,其中甲氧西林耐药者9株及肠球菌10株。药敏试验结果显示,萆薢分清丸联合左氧氟沙星对多重耐药细菌所致下尿路感染的总有效率为78.2%(18/23),细菌学总有效率为73.9%(17/23),与对照组比较(总有效率为45.0%,细菌学总有效率为25.0%)均差异有统计学意义(P<0.05)。未发生与药物相关的严重不良事件。结论急诊病人常见的尿路感染病原菌中多重耐药细菌比例高,萆薢分清丸联合左氧氟沙星用于治疗多重耐药菌引起的尿路感染疗效良好。
